NEW YORK (GenomeWeb) – Fluidigm said this week it has entered into a licensing agreement with Baylor Genetics for a next-generation sequencing library prep assay for the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Under the terms of the agreement, Fluidigm has the right to commercialize the CFTR prep assay for research use on its Juno automated microfluidic system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.

Dec
05
Sponsored by
Agilent

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.